Aquí encontrará nuestros anuncios más recientes, que incluyen asociaciones, lanzamientos de productos y éxitos de pruebas. Lea a continuación para conocer nuestros anuncios más recientes.
ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for treatment of migraines.
ObvioHealth, in partnership with IQVIA Consumer Health, announces the launch of a fully decentralized clinical trial with Jovie USA to bring an innovative goat milk-based infant formula to the United States.
ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface (API) tailored specifically for digital therapeutic (DTx) clinical trials.
ObvioHealth and Sterling IRB today announce a partnership to help speed access and adoption of decentralized clinical trials. The partnership makes Sterling IRB the preferred Institutional Review Board for ObvioHealth.
ObvioHealth announces it has been rated as the top “major contender” on Everest Group’s 2022 PEAK Matrix®, an industry report providing analysis and insights on decentralized clinical trial vendors. ObvioHealth is ranked 5th overall in a field of 24 industry players.